Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 1:39 AM ET

Biotechnology

Company Overview of Elcelyx Therapeutics, Inc.

Key Executives for Elcelyx Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Alain D. Baron M.D.15 RelationshipsChief Executive Officer, President, and Director60
Ralph E. Christoffersen Ph.D., J.D.74 RelationshipsExecutive Officer and Chairman76
Theodore A. Laufik 6 RelationshipsExecutive Officer and Director--
Martin R. Brown No RelationshipsChief Business Officer67
Mark C. Wiggins 14 RelationshipsSenior Vice President of Business Development58

Elcelyx Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ralph E. Christoffersen Ph.D., J.D. 74 RelationshipsElcelyx Therapeutics, Inc.76
Alain D. Baron M.D. 15 RelationshipsNaZura BioHealth, Inc.60
Theodore A. Laufik 6 RelationshipsElcelyx Therapeutics, Inc.--
Brook H. Byers Ph.D., MBA 167 RelationshipsKleiner Perkins Caufield & Byers69
James W. Glasheen Ph.D. 45 RelationshipsTechnology Partners46
View All Board Members

Elcelyx Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
368.4K
Bonus
243.1K
Total Short Term Compensation
458.1K
Total Value of Options
37.1M
Compensation as of Fiscal Year
Elcelyx Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elcelyx Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.